HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.

Abstract
Thrombospondin-1 is an extracellular matrix protein that inhibits endothelial cell proliferation, migration, and angiogenesis. This study was performed to investigate the role of thrombospondin-1 in ischemic retinal neovascularization. In a murine model of retinal neovascularization, thrombospondin-1 mRNA was increased from postnatal day 13 (P13), with a threefold peak response observed on P15, corresponding to the time of development of retinal neovascularization. Prominent expression of thrombospondin-1 was observed in neovascular cells, specifically, cells adjacent to the area of nonperfusion. It has been suggested that vascular endothelial growth factor (VEGF) plays a major role in ischemia-induced retinal neovascularization of this model, so we studied the effects of VEGF on thrombospondin-1 expression. In bovine retinal microcapillary endothelial cells, VEGF induced a biphasic response of thrombospondin-1 expression; VEGF decreased thrombospondin-1 mRNA 0.41-fold after 4 hours, whereas it increased, with a threefold peak response, after 24 hours. VEGF-induced endothelial cell proliferation was completely inhibited by exogenous thrombospondin-1 and increased by 37.5% with anti-thrombospondin-1 antibody. The present findings suggest that, in the ischemic retina, retinal neovascular cells increase thrombospondin-1 expression, and VEGF may stimulate endogenous thrombospondin-1 induction, which inhibits endothelial cell growth. VEGF-mediated thrombospondin-1 induction in ischemia-induced angiogenesis may be a negative feedback mechanism.
AuthorsK Suzuma, H Takagi, A Otani, H Oh, Y Honda
JournalThe American journal of pathology (Am J Pathol) Vol. 154 Issue 2 Pg. 343-54 (Feb 1999) ISSN: 0002-9440 [Print] United States
PMID10027393 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelial Growth Factors
  • Lymphokines
  • RNA, Messenger
  • Thrombospondin 1
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Cycloheximide
Topics
  • Animals
  • Animals, Newborn
  • Cattle
  • Cells, Cultured
  • Cycloheximide (pharmacology)
  • Disease Models, Animal
  • Endothelial Growth Factors (pharmacology)
  • Endothelium, Vascular (drug effects, metabolism, pathology)
  • Female
  • Humans
  • Infant, Newborn
  • Ischemia (metabolism, pathology)
  • Lymphokines (pharmacology)
  • Mice
  • Mice, Inbred C57BL
  • Pregnancy
  • RNA, Messenger (biosynthesis)
  • Rats
  • Retinal Neovascularization (etiology, metabolism, pathology)
  • Retinal Vessels (drug effects, metabolism, pathology)
  • Retinopathy of Prematurity (etiology, metabolism, pathology)
  • Thrombospondin 1 (genetics, metabolism)
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: